LAVA Therapeutics N.V.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy LAVA Therapeutics N.V. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for LAVA Therapeutics N.V. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for LAVA Therapeutics N.V. is LVTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
LAVA Therapeutics N.V. has its primary listing on NASDAQ. You can trade LAVA Therapeutics N.V. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, LAVA Therapeutics N.V. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include LAVA Therapeutics N.V. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like LAVA Therapeutics N.V..